TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

REDDYS

DermatologyNeurologyImmunology
Generics

REDDYS is a generic drug manufacturer focused on Dermatology, Neurology, Immunology.

2010
Since
3
Drugs
-
Trials
54
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

DIVALPROEX SODIUM 2026-01-29
Labeling
DIVALPROEX SODIUM 2026-01-29
Labeling
DIVALPROEX SODIUM 2026-01-28
Labeling
DIVALPROEX SODIUM 2026-01-28
Labeling
DIVALPROEX SODIUM 2026-01-24
Labeling
DIVALPROEX SODIUM 2026-01-24
Labeling
DIVALPROEX SODIUM 2026-01-24
Labeling
DIVALPROEX SODIUM 2025-09-19
Labeling
DIVALPROEX SODIUM 2025-09-19
Labeling
DIVALPROEX SODIUM 2025-09-02
Labeling
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Dermatology 39%
0 drugs Phase 3: 2 Phase 2: 2
Neurology 29%
0 drugs Phase 3: 1 Phase 2: 2 Phase 1: 1
Immunology 19%
0 drugs Phase 3: 1 Phase 2: 1
Oncology 13%
0 drugs Phase 3: 1

Pipeline Strength Pro

Loading...

Competitors Pro

Eli Lilly big-pharma
Oncology, Immunology, Neurology, Dermatology
Pfizer big-pharma
Oncology, Dermatology, Immunology
AbbVie big-pharma
Immunology, Oncology, Neurology
GSK big-pharma
Oncology, Immunology, Neurology
Roche big-pharma
Oncology, Neurology, Immunology